Sitemap - 2010 - The California Stem Cell Report
California Stem Cell Agency Expanding Staff, Looking for a Few New Hires
CIRM Directors Move Towards Wider Public Access in Chair Selection
Nature Magazine Says Bernstein Is Still A Possibility for CIRM Chair
UCSD's Goldstein Says His CIRM Grants Not All Basic Research
Brown and Newsom to Nominate Two of the Next CIRM Chair Candidates
Torres and Roth Re-elected as CIRM Vice Chairs
Klein Given New, Six-Month Term as Chairman; Board to Examine Criteria for Replacement
CIRM Directors Convene Behind Closed Doors to Consider Election of Chairman
CIRM Board Attorney Challenges Assessment of Klein's Financial Warning
California Stem Cell Researcher Says Election Ruckus Is Damaging CIRM
The Pros and Cons of Retaining Klein as Chair of the California Stem Cell Agency
The Biopolitical Times Recounts the "Sordid" Saga at CIRM
Klein's Fiscal Warning Does Not Match Up with State Treasurer's Account
Business Reporter Pokes Fun at Stem Cell Agency Election Process
CIRM Director Lansing Backs Klein Re-election
Klein's Fiscal Warnings at Odds With His Rosy View 11 Days Ago
Eve of the CIRM Election: Klein Invokes Sudden Financial Warning
More Coverage of Call for Delay in CIRM Chairman Election
Klein's Collateral Damage: Delay Needed in CIRM Chair Election
CIRM Director Prieto Weighs in on Letter From Scientists
Top California Official Urges Suspension of CIRM Chair Election
Eleven Top Stem Cell Researchers Back Klein for Re-election
Torres Withdraws from Contest for CIRM Chair , Klein Now a Shoo-In
The Odd Business of Electing a New CIRM Chair, Plus Klein Says No to Salary
More Than You Want to Know About Serial Meetings
No Real Problem with Canadians as CIRM Chair
CIRM Board Meeting Back Online
CIRM Directors Resume Public Meeting
Trounson on Recommendations of Blue-ribbon Reviewers
CIRM Press Release on External Review Report
Stem Cell Agency Board Still in Closed Session
Klein Addresses CIRM Board on His Succession Moves
Klein Defends Role in Selection of Successor
CIRM Directors Probe New Directions for Stem Cell Agency
The Canadian Citizenship Question: Day Three
Read This Item to See What CIRM Has Expunged From Its Web Site
Canadians No, Australians Yes?
Is Klein a Shoo-In for Chair of California Stem Cell? Maybe, Maybe Not
Klein's Maneuvers, CIRM's Reputation and Bernstein's
CIRM Director Prieto Comments on Transparency
Klein's Re-nomination Almost Unnoted in Major Media
Questions Raised About Klein Campaign to Pick His Own Successor
Klein Removes Ambiguity and Says He Will Seek 12-month Term
Klein's Careful Statement on Re-nomination
Klein Re-Nominated for Chair of California Stem Cell Agency
Bernstein Drops Out of Race for CIRM Chair
Stem Cell Chairmanship Flap Draws Major Media Coverage
Closed-Door Portola Valley Plan to Install Bernstein as New Chair of CIRM
CIRM Defends Its Information Practices
Torres, Sheehy Nominated for CIRM Chair and Vice Chair Respectively
Trounson and Torres and the Battle for Chair of the California Stem Cell Agency
Public and Industry Left in Dark by California Stem Cell Agency
Nature Reports on CIRM External Review and Industry Reaction
Torres and Bernstein Mentioned as Potential Candidates for CIRM Chair
BioTime and CIRM Join in hESC Deal
Biotech Exec Says CIRM Review Misguided, Biased and Disservice to Public
Bee Readers' Commentary on CIRM Not Warm and Fuzzy
The California Stem Cell Agency and the Promises of its Creators
Text of Bee Article on the State of Affairs at CIRM
Recommendations for CIRM from Blue-ribbon Panel
CIRM Management Stumbling at Routine Tasks
California Stem Cell News: A Not-So-Good Story Line
Second hESC Trial Scores Significant Media Coverage
California Stem Cell Directors Take Up Klein's New Role, Future Priorities
Knoepfler: NY Times Piece on Stem Cells Not Up to Snuff
Kerfuffle over NY Times Take on California's Stem Cell Program
Coffey Not Committed to Moving to California Despite $4.9 Million Grant from CIRM
Slim Coverage Today of California Stem Cell Agency Awards
Stem Cell Agency Approves More than $70 Million Including Signing Bonus for Star at UCSB
$80 Million to Be Given Way Later Today
City of Hope Scientist Seeks to Reverse Negative Finding on Grant Application
How Fast Should the Stem Cell Agency Spend its Remaining $1.6 Billion?
CIRM Poetry Kerfuffle Attracts More Publicity
Final Wrap-up for Blue Ribbon Review of California Stem Cell Agency
Does the Stem Cell Agency Have Enough 'Bandwidth' to Do The Job?
Blue-Ribbon Panel Hears Recommendations for More Openness at California Stem Cell Agency
Public Still Barred from Sweeping CIRM Review
More Time for Public Comment at CIRM Review But Doors Still Closed Otherwise to Public
Stem Cell Agency Apologizes for Its Choice of Poetry
Parsing Statistics vs. the Reality of Biotech Concerns About CIRM
Stem Cell Agency Says It Is "Not Biased Against Industry"
Full BayBio Report on Lack of CIRM Grants to Business
CIRM Directors to Consider $600,000 Online Journal Plan
The Biotech Industry and the California Stem Cell Agency: An Unhappy Relationship
California Stem Cell Report Honored as One of The Best Stem Cell Blogs
Candidates Sought for Board of California Stem Cell Agency
Public and Scientists Left in Lurch on Proposals Affecting $2 Billion in Taxpayer Funds
One Hour Public Access at Critical Two-Day Review of $3 Billion State Stem Cell Operation
Credibility Damaged and Foes Aided: No Upside on CIRM's Ban on the Public
Text of CIRM Board Members Responses on Public Ban at External Review
National Stem Cell Doings: Rat Brains and Legal Wrangling
Implications of a New Multibillion Dollar Bond Campaign for CIRM
Stem Cell Agency Bans Public from Critical Review of its Operations
Text of CIRM Comments on October Review of its Operations
Text of Consumer Watchdog Remarks on Closing of CIRM External Review
More Details on Jockey Martinez' Bid to Enroll in Geron Clinical Trial
Competing for Dollars: CIRM Examining Grant Ground Rules
CSCR Reading List: Grant Appeals at the California Stem Cell Agency
Northwestern Is Lead Site for Geron hESC Trial
Clinical Trial Challenges: The Matter of Michael Martinez
Embryonic Stem Cell Treatment Ruled Out for California Jockey
More Info on hESC Treatment of Jockey with Severed Spinal Cord
Chronicle Reports Possible hESC Treatment of Severed Spinal Cord
CIRM Leads National Effort to Forge 'Pathways' with FDA
CIRM Salaries: More Than You Want to Know
CSCR Reading List: Salaries at the California Stem Cell Agency
Legal Wheels Turn: Ban on hESC Funding Temporarily Removed
Time to Let Lawmakers Know What They Need to Do
CIRM Moves Ahead on $50 Million Clinical Trial Round
Legislation to Give CIRM More Employees Goes to Governor
CIRM's Sheehy Says CIRM to Pay Off in Cures and Economic Development
California Radio Talk Show on hESC Ruling
The Latest from the NIH re the hESC Ruling
Media Coverage: Political and Research Implications of hESC Ruling
CIRM Director Prieto Says hESC Research Ruling 'Almost Beyond Belief'
California Stem Cell Agency Deplores Ruling Nixing Fed hESC Research
The $3 Billion Question: Kids, Scientists and CIRM
Massive, $243 Million Disease Round Gets Okay from Stem Cell Agency
Today's Board Meeting Coverage Cancelled; Tomorrow's Still On
Coverage of Today's Stem Cell Board Meeting
Belated Info on Election of New CIRM Chair, $120 Million Grant Round and Costly CIRM Study
CIRM Hiring of Former Geron Exec Raises Conflict of Interest Questions
Economic Interest Statements of CIRM Directors Posted Online by California Stem Cell Report
Dismal Lead-Up to CIRM Board Meeting Next Week
$1 Million Evaluation of Stem Cell Agency Comes Up Next Week
Cedar-Sinai's Melmed Named to CIRM Board
Emotionalism and Potential Favoritism Cited as Need for Changes in CIRM Grant Appeals
Stem Cell Directors Putting Off More Recruitment Grant Decisions
CIRM Directors Pay Proposal Advances; Another Openness Failure on Grants Management System
Extremely Modest Coverage of Wechsler-Reya Signing; Status of Tannishtha Unclear
It's Official: Wechsler-Reya Signs with Sanford-Burnham
California Gains Two Bright Stem Cell Stars from Duke
Geron's Clinical Trial: Risk, Front-loading and Costs
Geron Go-Ahead Rouses Industry and Researchers
Pay Proposal for Patient Advocates on CIRM Board
Managing More than 300 Grants: CIRM's Thin Ice Question
Jonny and His Stem Cell Breakdown
Despite New CEO Job, Alan Lewis to Continue to Consult for CIRM
CIRM's New Interim VP for Research Takes Job with San Diego Firm
A Matter for CIRM to Ponder: California's Visceral Reaction to High Salaries for Public Servants
CIRM Defends Legality of Barring Public From Marriott Meeting
Questions and Commentary on Stem Cell Reprogramming
Day 153 of the Wechsler-Reya Affair: Near Silence from All Quarters
Stem Cell Directors Postpone Action on Troubled Appeals Process
Biopolitical Times Questions Rationale for Future CIRM Funding
CIRM Seeks Communications Coordinator
UC Davis Scientist Praises CIRM Appeals Change
Whither Wechsler-Reya? A $6 Million Stem Cell Tale
CIRM Finally Discloses Grant Appeal Proposals
Sticky, Troubling Appeals by Rejected Researchers Targeted by Stem Cell Agency
New CIRM VP Lewis and Ambit Biosciences
Appeals on Stem Cell Grant Applications: CIRM's Upcoming Re-examination
Klein Defends Burgeoning CIRM Budget
SF Lawyer Urges Openness at Stem Cell Agency
Campaign Contributors, iPierian and the California Stem Cell Agency
CIRM Improving Web Site, Easier to Navigate, Better Organized
Watered-Down Reform Bill Moving Ahead; CIRM Looking at Boosting Staff to as High as 60
CIRM's Self Interest Demands More Openness
The Agenda from the Incident at the Marriott
Comment on Lewis' $250,000 Contract
$250,000, Six-Month Contract for CIRM's Lewis
Alan Lewis Joins CIRM as VP for Research and Development
Escape Therapeutics: The Latest Business to Win a CIRM Grant
"Seduction" -- A Poem by a Stem Cell Scientist
Former Novocell/JDRF Chief Hooking Up With CIRM
Top 10 Tips for Snagging Cash from CIRM
Stem Cell Information Resource
Biopolitical Times Says More Openness Needed at CIRM
Tracking CIRM Grants: "Thin Ice" Lurking?
'Troubling' Trend: Is CIRM Playing Field Level for Business?
CIRM Directors Discuss Strategic Financing Plans
More Live Coverage Today: CIRM Budget and Financial Projections
Immunology Grants: CIRM Gives $25 Million to 19 Researchers
CIRM Board Moves to Closed Door Session
CIRM Board Begins Consideration of Immunology Grants
CIRM Board in Executive Session
Scripps' Loring on CIRM Grant Petitions
Live Coverage of CIRM Board Meeting
CIRM Challenged by Nine Scientists on Negative Grant Decisions
Kleiner Piece Listed in 'Best of Web'
Stem Cell Agency Budget Soars 28 Percent
More Grant Appeals Filed: Yamanaka Invoked
Incident at the Marriott: Stem Cell Agency Bars Public From Meeting
Six Scientists Appeal Rejection of Grants; Read Their Letters to CIRM
Fresh Info, and Plenty of It, From CIRM for Big Meeting Next Tuesday
Campaign Contributions, Kleiner Perkins, iPierian and CIRM Grant
Text of CIRM Response on iPierian Grant and Campaign Contribution
Read Reviewer Remarks on 45 Applications for California Stem Cell Grants
The Latest on Calimmune and California Cash
State of Stem Cell Research Examined This Morning
California Stem Cell Directors to Give Away $30 Million Next Week and Tackle Budget
Budget Contretemps: CIRM Takes Another Run at Spending Plan
CIRM's Budget Preparation Problems a 'Bit Alarming'
Stem Cell Agency Calls Off Budget Session: No Public Info Available
CIRM Stiffs Public on Spending Plan
Aussie Stem Cell Scientists Looking for Help From California
A Commentary on Cobbling Together CIRM Numbers
Move to Allow Stem Cell Agency More Staff Advances in Legislature
CIRM Directors Judge Klein's Performance This Week
CIRM Seeking $210,000 in PR Help
IOM Study of CIRM to Come Before Stem Cell Directors in August
CIRM Grant Appeal Rules to Receive More Scrutiny
Reading List on CIRM Grant Appeals
CIRM Directors Okay Compromise Legislation
CIRM Comments on New NIH Disclosure Rules
IOM Proposal Not So Good, Says One CIRM Director
State's Top Fiscal Officer Lauds Disclosure Proposal Likely to Affect CIRM
Stem Cell Grant Competition: Remove CIRM Directors From Appeals?
CIRM Takes a Crack at Stem Cell Banking
Bee Carries Article on Stem Cell Agency and the State's Financial Crisis
Players in the Negotiations on the CIRM Cap Removal Legislation
Compromise on Legislation Removing CIRM Staff Cap
New NIH Conflict Rules and Their Impact on CIRM
IOM Study of California Stem Cell Agency Proposed
CIRM Legislation Noted on HealthyCal
Competing for California Stem Cell Cash: Rules of the Game Coming Under Scrutiny
The Folly of Ballot Box Budgeting and Stem Cell Research
Longtime CIRM Watchdog Expanding Beyond Stem Cells
Irvine Opens New Home for 60 Stem Cell Researchers
CIRM Staff Cap/Reform Legislation Hanging Fire
CIRM Cancels Board Meeting on Compromise Reform Legislation
Negotiations Underway on CIRM Reform Legislation; Staff Cap Removal Included
Keeping the Cash in California: CIRM's Rules
Parochial or Global? The California Research Spending Rule and Science
WARF Loses Latest Round on Challenge to hESC Patents
More Info on Palo Alto Institute Grant
Modest Coverage of Wechsler-Reya Recruitment
Stem Cell Agency Seeking Legislative Removal of 50-person Staff Cap
Scanty Coverage of CIRM's $28 Million in Grants
$22 Million for Biology: CIRM Directors OK Two Reviewer-rejected Grants
Duke Researcher Wins $6 million Grant From California -- With a Condition
CIRM Directors Meeting Underway
CIRM Receives Another $112 Million
California Stem Cell Directors End Public Session Tonight
$5.9 Million Grant to Duke Scientist Moving Forward Again
CIRM Directors with Conflicts of Interests on Biology Grants
Live Coverage of Today's CIRM Directors Meeting
Action Stalled on $5.9 Million CIRM Grant to Recruit Duke Scientist
Wechsler-Reya Still Mulling Move to California's Burnham
CIRM Millions To Help Snag Duke star Wechsler-Reya for Burnham
CIRM's Nearly $6 Million Carrot
Remcho Up for 30 Percent Hike at CIRM; Contracting Changes Also on Table
CIRM Directors to Hand Out $30 Million and Wrestle with Contracting Policies
CIRM Reform Legislation Advances in Senate
Exciting(?) California Stem Cell News Upcoming
Latest on New CIRM VP and Compensation
Geron and ACT Could Apply in $50 Million Clinical Trial Loan Program
Ipierian to Seek Multimillion Clinical Trial Loan from CIRM
High Costs of Stem Cell Therapy: Will Stem Cell Firms Share More Risk?
CIRM Moving to Hire VP at More Than $332,000
Trounson's Criteria for New CIRM Chairman
Accountability and Umbilical Cord Blood Legislation: CIRM's Positions
Capitol Newspaper Explores CIRM Accountability Issues
Reading List on CIRM Conflicts of Interest
Fomer Top Exec at CIRM Hired by San Diego Firm
CIRM Directors Take Up Evaluation of Top Management
California Stem Cell Matters: What Do You Think?
Snyder says CSCR Headline Lacks Impartiality
Nature Blogger Writes About Snyder Grant
Burnham's Snyder Receives $1.85 Million More Despite Faulty Application
CIRM Okays First Clinical Trial Round; $50 Million Earmarked
CIRM VP Salary Hike Move Delayed
$62 Million Effort: First CIRM-financed Lab Opens at UC Davis
Live Coverage Today of CIRM Board Meeting
Snyder Provides Additional Comment on Out-of-State Spending Proposal
Murky Backdrop on $5.4 Million Grant to Burnham Scientist
Text of Simpson Comment on Snyder Grant
Text of Snyder Comment on his CIRM Grant
Correction and More Details on Snyder Grant
$50 Million Clinical Trial Effort Proposed to CIRM Directors
Communications Subcommittee Meeting Delayed
CIRM Director Prieto's Comments
CIRM Moves Adroitly in Attempt to Sidetrack Legislation
Text of CIRM Comments on Alquist Legislation
School Children vs. Stem Cell Scientists; A Public Perception Problem
Telling the California Stem Cell Story: $1 Million for PR/Communications and More Likely
Analysis of CIRM Challenges on HealthyCal
Stem Cell Agency Launches High School Education Effort
CIRM Directors to Take Position on Affordability, Accountability Measure
CIRM Director Azziz Looking to Move to Georgia
CIRM Trio Says Alquist Legislation Creates Unnecessary Jeopardy
State Lawmaker Says CIRM 'Accountable to No One'
California Lawmakers to Weigh Stem Cell Agency Reform
Attention Scientists: CIRM Is Changing Grant Rules
No Ten Year 'Sunset' on CIRM Horizon
Statement on CIRM's Life Span From the Agency's Counsel
Eugene Washington to Join CIRM Board
Southern California Newspaper Calls for Greater Transparency at CIRM
CIRM Financially Secure Into Summer 2011
CIRM Directors Change Big Biotech Loan Program
Scathing Commentary on CIRM from San Diego Union-Tribune
The Latest on Changes in CIRM's Biotech Loan Program
Fecundity, Stem Cells and the Dark Side of Prop. 71
CIRM Delays Action on Clinical Trials, Biotech Loan Changes
LA Times on CIRM Plans to Remain 'Relevant'
LA Times Columnist Targets CIRM; Structural Changes Needed
CIRM Clinical Trial and Biotech Industry Loan Plans Remain Veiled
CIRM Proposes $40 Million Stem Cell "Tools" Round; Board Meeting Accessible in LA
CIRM Disagrees with Many Recommendations for More Openness
Big Buck Stem Cell Plans Shrouded by CIRM Transparency Failure
CIRM Oversight Panel Recommends More Accountability, Transparency at Agency
CIRM Adheres to Core Mission but Future is Challenge
CIRM Moving to Fund Clinical Trials
CIRM Finances On Table Next Tuesday
Changes Looming in California's Biotech Loan Program
California Stem Cell Lab Construction Not Entirely Up to Snuff